Sunday, September 24, 2023

Radiation Therapy According To Cancer Types


External Beam Radiation therapy for Thyroid Cancer

Postoperative External Beam Radiotherapy for Differentiated Thyroid ...

External beam Radiation therapy uses high-energy rays (or particles) to destroy cancer cells or slow their growth. A carefully focused beam of radiation is delivered from a machine outside the body.

This type of Radiation therapy is most often used to treat medullary thyroid cancer and anaplastic thyroid cancer. For cancers that take up iodine (most differentiated thyroid cancers) radioiodine therapy is usually a better treatment.

External beam Radiation therapy is often used for cancers that do not take up iodine and have spread beyond the thyroid. This might be done to help treat the cancer or to lower the chance of cancer coming back in the neck after Surgery.

If a cancer does not respond to radioiodine therapy, external Radiation therapy may be used to treat cancer that has come back in the neck or distant metastases that are causing Pain or other symptoms.

External beam Radiation therapy is usually given 5 days a week for several weeks. Before your treatments start, the medical team will take careful measurements to find the correct angles for aiming the radiation beams and the proper dose of radiation. The treatment itself is painless and much like getting a regular X-Ray. Each treatment lasts only a few minutes, although the setup time — getting you into place for treatment — usually takes longer.

Possible side effects

The main drawback of this treatment is that the radiation can destroy nearby healthy tissue along with the cancer cells. Some patients get skin changes similar to a sunburn, but this slowly fades away. Trouble swallowing, dry mouth, hoarseness, and Fatigue are also potential side effects of external beam Radiation therapy aimed at or near the thyroid.

To reduce the risk of side effects, doctors carefully figure out the exact dose needed and aim the beam as accurately as they can to hit the target.